Anthropic Buys Biotech Startup Coefficient Bio in $400M Deal

Anthropic Buys Biotech Startup Coefficient Bio in $400M Deal

Anthropic Acquires Coefficient Bio in a Shocking $400M Biotech Deal Anthropic has acquired Coefficient Bio, a stealth biotech AI startup, in a reported $400 million stock deal. The acquisition signals a dramatic acceleration of Anthropic's ambitions in healthcare and drug discovery, just months after the company launched its first dedicated life sciences product. If you have been watching the AI industry closely, this is a move you cannot afford to ignore. What Is Coefficient Bio and Why Does It Matter Coefficient Bio was not a household name, and that was entirely by design. Founded just eight months before the acquisition closed, the startup operated in stealth mode, quietly building AI tools aimed at making drug discovery and biological research faster and more efficient. Behind the company were two founders with serious credentials: Samuel Stanton and Nathan C. Frey. Both had worked at Genentech's Prescient Design, one of the most respected computational drug discovery units i…